Background and objective Worldwide adoption of the subcutaneous implantable
cardioverter‐defibrillator (S‐ICD) for preventing sudden cardiac death continues to increase …

Background The recently approved subcutaneous implantable cardioverter/defibrillator (S-
ICD) uses a single extrathoracic subcutaneous lead to treat life-threatening ventricular …

Background To date, general anesthesia has been suggested as the preferred approach for
implantation of a subcutaneous implantable cardioverter-defibrillator (S-ICD). The purpose …

Background The subcutaneous implantable cardioverter-defibrillator (S-ICD) system is an
established therapy for the prevention of sudden cardiac death (SCD) and an alternative to a …

The aim of this European Heart Rhythm Association (EHRA) prospective snapshot survey is
to assess peri-procedural practices, implantation techniques, and short-term procedure …

Background Subcutaneous implantable cardioverter defibrillator (S-ICD) system has been
proven to be an effective therapy for prevention of sudden cardiac death (SCD) in selected …

Objectives: This study assessed outcomes in patients in whom subcutaneous implantable
cardioverter-defibrillator (S-ICD) therapy was continued after implantation-related …

Background The subcutaneous implantable cardioverter-defibrillator (S-ICD) was developed
to reduce short-and long-term complications associated with transvenous ICD leads. Early …

Background: The entirely subcutaneous implantable cardioverter-defibrillator (S-ICD) is the
first implantable defibrillator that avoids placing electrodes in or around the heart. Two large …

Background: Implantation and testing of implantable defibrillators (ICDs) using local
anesthetic and conscious sedation is widely practiced; however, some centers still use …